tiprankstipranks
Trending News
More News >
Healthequity (HQY)
NASDAQ:HQY
US Market
Advertisement

Healthequity (HQY) Ratios

Compare
862 Followers

Healthequity Ratios

HQY's free cash flow for Q2 2026 was $0.71. For the 2026 fiscal year, HQY's free cash flow was decreased by $ and operating cash flow was $0.29. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
4.23 4.76 2.92 2.29 2.25
Quick Ratio
4.23 4.76 2.92 2.29 2.25
Cash Ratio
2.61 3.45 1.94 1.47 1.61
Solvency Ratio
0.24 0.18 0.11 0.07 0.09
Operating Cash Flow Ratio
3.15 2.07 1.15 0.92 0.89
Short-Term Operating Cash Flow Coverage
36.87 0.00 5.45 6.74 2.37
Net Current Asset Value
$ -777.42M$ -571.33M$ -810.37M$ -903.19M$ -871.10M
Leverage Ratios
Debt-to-Assets Ratio
0.31 0.29 0.32 0.32 0.40
Debt-to-Equity Ratio
0.49 0.46 0.52 0.54 0.78
Debt-to-Capital Ratio
0.33 0.31 0.34 0.35 0.44
Long-Term Debt-to-Capital Ratio
0.32 0.30 0.34 0.35 0.42
Financial Leverage Ratio
1.59 1.55 1.63 1.68 1.97
Debt Service Coverage Ratio
5.00 4.74 2.41 2.18 1.43
Interest Coverage Ratio
3.71 2.31 0.80 0.95 2.39
Debt to Market Cap
0.12 0.14 0.19 0.23 0.17
Interest Debt Per Share
12.92 11.55 12.35 12.57 14.95
Net Debt to EBITDA
1.85 1.87 4.32 7.60 4.82
Profitability Margins
Gross Profit Margin
66.43%62.29%56.87%56.00%56.62%
EBIT Margin
19.58%12.94%1.20%-3.99%5.32%
EBITDA Margin
31.96%28.25%19.90%13.61%21.12%
Operating Profit Margin
18.48%12.82%4.52%4.58%11.35%
Pretax Profit Margin
14.59%7.51%-4.42%-8.82%0.56%
Net Profit Margin
11.49%5.57%-3.03%-5.85%1.20%
Continuous Operations Profit Margin
11.49%5.57%-3.03%-5.85%1.20%
Net Income Per EBT
78.75%74.24%68.62%66.36%213.38%
EBT Per EBIT
78.98%58.56%-97.87%-192.69%4.97%
Return on Assets (ROA)
4.27%1.76%-0.85%-1.43%0.33%
Return on Equity (ROE)
6.85%2.74%-1.38%-2.39%0.64%
Return on Capital Employed (ROCE)
7.10%4.21%1.32%1.17%3.32%
Return on Invested Capital (ROIC)
5.56%3.11%0.89%0.77%6.84%
Return on Tangible Assets
23.67%8.20%-5.18%-9.07%1.43%
Earnings Yield
1.72%0.86%-0.51%-1.00%0.14%
Efficiency Ratios
Receivables Turnover
11.41 9.53 8.90 8.65 10.08
Payables Turnover
44.37 31.31 26.74 12.09 197.17
Inventory Turnover
0.00 0.00 371.66M 0.00 0.00
Fixed Asset Turnover
29.62 18.38 12.43 8.70 6.18
Asset Turnover
0.37 0.32 0.28 0.24 0.27
Working Capital Turnover Ratio
3.46 2.89 3.83 3.33 3.67
Cash Conversion Cycle
23.75 26.64 27.37 11.98 34.36
Days of Sales Outstanding
31.98 38.30 41.02 42.18 36.21
Days of Inventory Outstanding
0.00 0.00 <0.01 0.00 0.00
Days of Payables Outstanding
8.23 11.66 13.65 30.20 1.85
Operating Cycle
31.98 38.30 41.02 42.18 36.21
Cash Flow Ratios
Operating Cash Flow Per Share
4.24 2.84 1.78 1.70 2.45
Free Cash Flow Per Share
3.92 2.30 0.37 0.05 1.14
CapEx Per Share
0.32 0.54 1.41 1.65 1.31
Free Cash Flow to Operating Cash Flow
0.93 0.81 0.21 0.03 0.47
Dividend Paid and CapEx Coverage Ratio
13.45 5.27 1.26 1.03 1.87
Capital Expenditure Coverage Ratio
13.45 5.27 1.26 1.03 1.87
Operating Cash Flow Coverage Ratio
0.35 0.26 0.15 0.14 0.17
Operating Cash Flow to Sales Ratio
0.29 0.24 0.17 0.19 0.25
Free Cash Flow Yield
4.02%3.04%0.61%0.09%1.36%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
57.98 116.08 -196.55 -100.31 704.62
Price-to-Sales (P/S) Ratio
6.66 6.47 5.96 5.87 8.49
Price-to-Book (P/B) Ratio
3.94 3.18 2.71 2.40 4.51
Price-to-Free Cash Flow (P/FCF) Ratio
24.88 32.87 163.00 1.14K 73.53
Price-to-Operating Cash Flow Ratio
23.05 26.63 34.11 31.51 34.27
Price-to-Earnings Growth (PEG) Ratio
2.90 -0.37 4.73 0.19 -8.85
Price-to-Fair Value
3.94 3.18 2.71 2.40 4.51
Enterprise Value Multiple
22.69 24.77 34.27 50.75 44.99
Enterprise Value
9.20B 7.00B 5.88B 5.23B 6.97B
EV to EBITDA
22.69 24.77 34.27 50.75 44.99
EV to Sales
7.25 7.00 6.82 6.91 9.50
EV to Free Cash Flow
27.09 35.56 186.48 1.34K 82.34
EV to Operating Cash Flow
25.07 28.81 39.02 37.06 38.38
Tangible Book Value Per Share
-7.56 -5.25 -8.16 -9.22 -9.63
Shareholders’ Equity Per Share
24.80 23.78 22.45 22.28 18.57
Tax and Other Ratios
Effective Tax Rate
0.21 0.26 0.31 0.34 -1.13
Revenue Per Share
14.66 11.68 10.21 9.10 9.88
Net Income Per Share
1.69 0.65 -0.31 -0.53 0.12
Tax Burden
0.79 0.74 0.69 0.66 2.13
Interest Burden
0.75 0.58 -3.69 2.21 0.11
Research & Development to Revenue
0.20 0.22 0.22 0.21 0.17
SG&A to Revenue
0.09 0.10 0.11 0.11 0.12
Stock-Based Compensation to Revenue
0.06 0.08 0.07 0.07 0.06
Income Quality
2.52 4.36 -5.76 -3.18 20.56
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis